UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

A randomized study comparing yttrium‐90 ibritumomab tiuxetan (Zevalin) and high‐dose BEAM chemotherapy versus BEAM alone as the conditioning regimen before autologous stem cell transplantation in patients with aggressive lymphoma

Cancer, 2012-10, Vol.118 (19), p.4706-4714

2012

Volltextzugriff (PDF)

Staging of chronic myeloid leukemia in the imatinib era : An evaluation of the world health organization proposal

Cancer, 2006-03, Vol.106 (6), p.1306-1315

2006

Volltextzugriff (PDF)

Intracranial meningeal hemangiopericytoma: The role of radiotherapy: Report of 29 cases and review of the literature

Cancer, 2004-04, Vol.100 (7), p.1491-1497

2004

Volltextzugriff (PDF)

Imatinib mesylate causes hypopigmentation in the skin

Cancer, 2003-12, Vol.98 (11), p.2483-2487

2003

Volltextzugriff (PDF)

Meir Wetzler, MD

Cancer, 2015-07, Vol.121 (13), p.2106-2107

2015

Volltextzugriff (PDF)

Severe periorbital edema secondary to STI571 (Gleevec)

Cancer, 2002-08, Vol.95 (4), p.881-887

2002

Volltextzugriff (PDF)

Results of decitabine (5‐aza‐2′deoxycytidine) therapy in 130 patients with chronic myelogenous leukemia

Cancer, 2003-08, Vol.98 (3), p.522-528

2003

Volltextzugriff (PDF)

Complete cytogenetic and molecular responses to interferon‐α‐based therapy for chronic myelogenous leukemia are associated with excellent long‐term prognosis

Cancer, 2003-02, Vol.97 (4), p.1033-1041

2003

Volltextzugriff (PDF)

Homoharringtonine : History, current research, and future directions

Cancer, 2001-09, Vol.92 (6), p.1591-1605

2001

Volltextzugriff (PDF)

Chronic myelogenous leukemia: A review and update of therapeutic strategies

Cancer, 2003-08, Vol.98 (3), p.437-457

2003

Volltextzugriff (PDF)

Pure versus follicular variant of papillary thyroid carcinoma: Clinical features, prognostic factors, treatment, and survival

Cancer, 2003-03, Vol.97 (5), p.1181-1185

2003

Volltextzugriff (PDF)

The significance of myelosuppression during therapy with imatinib mesylate in patients with chronic myelogenous leukemia in chronic phase

Cancer, 2004-01, Vol.100 (1), p.116-121

2004

Volltextzugriff (PDF)

Long term tolerance of high dose three‐dimensional conformal radiotherapy in patients with localized prostate carcinoma

Cancer, 1999-06, Vol.85 (11), p.2460-2468

1999

Volltextzugriff (PDF)

Imatinib mesylate therapy improves survival in patients with newly diagnosed Philadelphia chromosome-positive chronic myelogenous leukemia in the chronic phase: Comparison with historic data

Cancer, 2003-12, Vol.98 (12), p.2636-2642

2003

Volltextzugriff (PDF)

Chromosomal abnormalities in Philadelphia chromosome‐negative metaphases appearing during imatinib mesylate therapy in patients with Philadelphia chromosome‐positive chronic myelogenous leukemia in chronic phase

Cancer, 2003-11, Vol.98 (9), p.1905-1911

2003

Volltextzugriff (PDF)

Chronic myelogenous leukemia in nonlymphoid blastic phase: Analysis of the results of first salvage therapy with three different treatment approaches for 162 patients

Cancer, 1999-12, Vol.86 (12), p.2632-2641

1999

Volltextzugriff (PDF)

Results of imatinib mesylate therapy in patients with refractory or recurrent acute myeloid leukemia, high‐risk myelodysplastic syndrome, and myeloproliferative disorders

Cancer, 2003-06, Vol.97 (11), p.2760-2766

2003

Volltextzugriff (PDF)

Survival benefit with imatinib mesylate therapy in patients with accelerated‐phase chronic myelogenous leukemia—Comparison with historic experience

Cancer, 2005-05, Vol.103 (10), p.2099-2108

2005

Volltextzugriff (PDF)

Pilot study of lonafarnib, a farnesyl transferase inhibitor, in patients with chronic myeloid leukemia in the chronic or accelerated phase that is resistant or refractory to imatinib therapy

Cancer, 2006-01, Vol.106 (2), p.346-352

2006

Volltextzugriff (PDF)

Effects of age on prognosis with imatinib mesylate therapy for patients with Philadelphia chromosome‐positive chronic myelogenous leukemia

Cancer, 2003-09, Vol.98 (6), p.1105-1113

2003

Volltextzugriff (PDF)

Results of triple therapy with interferon‐alpha, cytarabine, and homoharringtonine, and the impact of adding imatinib to the treatment sequence in patients with Philadelphia chromosome–positive chronic myelogenous leukemia in early chronic phase

Cancer, 2003-09, Vol.98 (5), p.888-893

2003

Volltextzugriff (PDF)

Granulocyte–colony‐stimulating factor (filgrastim) may overcome imatinib‐induced neutropenia in patients with chronic‐phase chronic myelogenous leukemia

Cancer, 2004-06, Vol.100 (12), p.2592-2597

2004

Volltextzugriff (PDF)

Imatinib mesylate therapy reduces bone marrow fibrosis in patients with chronic myelogenous leukemia

Cancer, 2004-07, Vol.101 (2), p.332-336

2004

Volltextzugriff (PDF)

High dose tumor necrosis factor‐α and melphalan administered via isolated limb perfusion for advanced limb soft tissue sarcoma results in a >90% response rate and limb preservation

Cancer, 1997-03, Vol.79 (6), p.1129-1137

1997

Volltextzugriff (PDF)

Erythropoietin is effective in improving the anemia induced by imatinib mesylate therapy in patients with chronic myeloid leukemia in chronic phase

Cancer, 2004-06, Vol.100 (11), p.2396-2402

2004

Volltextzugriff (PDF)

1 – 25 von 116

Suche als RSS-Feed

Aktive Filter

Zeitschrift / SerieCancer

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(116)
Mit Volltextzugriff
(116)

Publikationsform

Artikel
(116)

Sprache

Englisch
(116)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(100)
Oncology
(100)
Science & Technology
(100)
Humans
(98)
Biological And Medical Sciences
(85)
Medical Sciences
(84)
Middle Aged
(70)
Female
(64)
Adult
(62)
Male
(58)
Aged
(51)
Pharmacology. Drug Treatments
(32)
Hematologic And Hematopoietic Diseases
(29)
Leukemias. Malignant Lymphomas. Malignant Reticulosis. Myelofibrosis
(28)
Prognosis
(27)
Chronic Myelogenous Leukemia
(26)
Leukemia, Myelogenous, Chronic, Bcr-Abl Positive - Drug Therapy
(24)
Adolescent
(22)
Antineoplastic Agents
(22)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(22)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

Wiley Online Library
(116)
Wiley Online Library Full Collection 2018
(116)
EZB Electronic Journals Library
(116)
Ovid
(116)
Publisher or Other Site
(116)
Springer Book Series (Lecture Notes)
(111)
MEDLINE
(101)
IngentaConnect Journals
(6)

3 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

A randomized study comparing yttrium‐90 ibritumomab tiuxetan (Zevalin) and high‐dose BEAM chemotherapy versus BEAM alone as the conditioning regimen before autologous stem cell transplantation in patients with aggressive lymphoma

Staging of chronic myeloid leukemia in the imatinib era : An evaluation of the world health organization proposal

Intracranial meningeal hemangiopericytoma: The role of radiotherapy: Report of 29 cases and review of the literature

Imatinib mesylate causes hypopigmentation in the skin

Meir Wetzler, MD

Severe periorbital edema secondary to STI571 (Gleevec)

Results of decitabine (5‐aza‐2′deoxycytidine) therapy in 130 patients with chronic myelogenous leukemia

Complete cytogenetic and molecular responses to interferon‐α‐based therapy for chronic myelogenous leukemia are associated with excellent long‐term prognosis

Homoharringtonine : History, current research, and future directions

Chronic myelogenous leukemia: A review and update of therapeutic strategies

Pure versus follicular variant of papillary thyroid carcinoma: Clinical features, prognostic factors, treatment, and survival

The significance of myelosuppression during therapy with imatinib mesylate in patients with chronic myelogenous leukemia in chronic phase

Long term tolerance of high dose three‐dimensional conformal radiotherapy in patients with localized prostate carcinoma

Imatinib mesylate therapy improves survival in patients with newly diagnosed Philadelphia chromosome-positive chronic myelogenous leukemia in the chronic phase: Comparison with historic data

Chromosomal abnormalities in Philadelphia chromosome‐negative metaphases appearing during imatinib mesylate therapy in patients with Philadelphia chromosome‐positive chronic myelogenous leukemia in chronic phase

Chronic myelogenous leukemia in nonlymphoid blastic phase: Analysis of the results of first salvage therapy with three different treatment approaches for 162 patients

Results of imatinib mesylate therapy in patients with refractory or recurrent acute myeloid leukemia, high‐risk myelodysplastic syndrome, and myeloproliferative disorders

Survival benefit with imatinib mesylate therapy in patients with accelerated‐phase chronic myelogenous leukemia—Comparison with historic experience

Pilot study of lonafarnib, a farnesyl transferase inhibitor, in patients with chronic myeloid leukemia in the chronic or accelerated phase that is resistant or refractory to imatinib therapy

Effects of age on prognosis with imatinib mesylate therapy for patients with Philadelphia chromosome‐positive chronic myelogenous leukemia

Results of triple therapy with interferon‐alpha, cytarabine, and homoharringtonine, and the impact of adding imatinib to the treatment sequence in patients with Philadelphia chromosome–positive chronic myelogenous leukemia in early chronic phase

Granulocyte–colony‐stimulating factor (filgrastim) may overcome imatinib‐induced neutropenia in patients with chronic‐phase chronic myelogenous leukemia

Imatinib mesylate therapy reduces bone marrow fibrosis in patients with chronic myelogenous leukemia

High dose tumor necrosis factor‐α and melphalan administered via isolated limb perfusion for advanced limb soft tissue sarcoma results in a >90% response rate and limb preservation

Erythropoietin is effective in improving the anemia induced by imatinib mesylate therapy in patients with chronic myeloid leukemia in chronic phase

Aktive Filter

Suchergebnisse filtern